ArticleThe Journal of allergy and clinical immunology2022

Spontaneous NLRP3 inflammasome-driven IL-1-β secretion is induced in severe COVID-19 patients and responds to anakinra treatment.

Arinna Bertoni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.